OS Therapies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OS Therapies Incorporated (OSTX) on February 13, 2026, covering events occurring on February 10, 2026. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Grasonville, Maryland.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a capital structure event involving warrant exercises.
Material Changes and Events
- Warrant Inducement Extension: The Company extended the offering period for a warrant inducement transaction originally scheduled to expire on February 10, 2026, to 11:59 p.m. Eastern time on March 2, 2026.
- Transaction Details: On January 10, 2026, the Company entered into agreements with less than 10 accredited investors to exercise existing warrants for up to 5,382,148 shares of common stock.
- Exercise Price: The reduced exercise price is $1.40 per share (or $1.399 per share for pre-funding).
- New Warrants Issued: In consideration for the exercise, the Company agreed to issue new warrants to purchase up to 5,382,148 shares at an exercise price of $1.40 per share, subject to adjustment.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the warrant transaction mechanics. The extension of the offering period indicates the Company is seeking to maximize participation in the inducement offer.
Investor Verification Checklist
- Verify the total number of shares actually exercised and the cash proceeds received by the Company by the new deadline of March 2, 2026.
- Confirm the dilution impact of the 5,382,148 new shares and the issuance of 5,382,148 new warrants on existing shareholders.
- Review the specific adjustment provisions for the new warrants to understand potential future dilution scenarios.
- Check subsequent filings for the final closing of the transaction and the updated capitalization table.